Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency

CD1d-restricted natural killer T (NKT) cells, expressing the invariant T cell antigen receptor (TCR) chain encoded by Vα14-Jα18 gene segments in mice and Vα24-Jα18 in humans [invariant NKT (iNKT) cells], contribute to immunoregulatory processes, such as tolerance, host defense, and tumor surveillance. iNKT cells are positively selected in the thymus by CD1d molecules expressed by CD4+/CD8+ cortical thymocytes. However, the identity of the endogenous lipid(s) responsible for positive selection of iNKT cells remains unclear. One candidate lipid proposed to play a role in positive selection is isoglobotrihexosylceramide (iGb3). However, no direct evidence for its physiological role has been provided. Therefore, to directly investigate the role of iGb3 in iNKT cell selection, we have generated mice deficient in iGb3 synthase [iGb3S, also known as α1–3galactosyltransferase 2 (A3galt2)]. These mice developed, grew, and reproduced normally and exhibited no overt behavioral abnormalities. Consistent with the notion that iGb3 is synthesized only by iGb3S, lack of iGb3 in the dorsal root ganglia of iGb3S-deficient mice (iGb3S−/−), as compared with iGb3S+/− mice, was confirmed. iGb3S−/− mice showed normal numbers of iNKT cells in the thymus, spleen, and liver with selected TCR Vβ chains identical to controls. Upon administration of α-galactosylceramide, activation of iNKT and dendritic cells was similar in iGb3S−/− and iGb3S+/− mice, as measured by up-regulation of CD69 as well as intracellular IL-4 and IFN-γ in iNKT cells, up-regulation of CD86 on dendritic cells, and rise in serum concentrations of IL-4, IL-6, IL-10, IL-12p70, IFN-γ, TNF-α, and Ccl2/MCP-1. Our results strongly suggest that iGb3 is unlikely to be an endogenous CD1d lipid ligand determining thymic iNKT selection.

[1]  Anneliese O. Speak,et al.  Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals , 2007, Proceedings of the National Academy of Sciences.

[2]  D. Pellicci,et al.  Chewing the fat on natural killer T cell development , 2006, The Journal of experimental medicine.

[3]  R. Dwek,et al.  Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases , 2006, The Journal of experimental medicine.

[4]  P. Savage,et al.  Cutting Edge: Impaired Glycosphingolipid Trafficking and NKT Cell Development in Mice Lacking Niemann-Pick Type C1 Protein1 , 2006, The Journal of Immunology.

[5]  P. Savage,et al.  Mechanisms imposing the Vβ bias of Vα14 natural killer T cells and consequences for microbial glycolipid recognition , 2006, The Journal of experimental medicine.

[6]  P. Wang,et al.  Synthesis and biological evaluation of α-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3) , 2006 .

[7]  M. Sandrin,et al.  The Molecular Basis for Galα(1,3)Gal Expression in Animals with a Deletion of the α1,3Galactosyltransferase Gene12 , 2006, The Journal of Immunology.

[8]  B. Beutler,et al.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.

[9]  R. Sinden,et al.  Invariant Vα14 Chain NKT Cells Promote Plasmodium berghei Circumsporozoite Protein-Specific Gamma Interferon- and Tumor Necrosis Factor Alpha-Producing CD8+ T Cells in the Liver after Poxvirus Vaccination of Mice , 2005, Infection and Immunity.

[10]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[11]  Michael B Brenner,et al.  CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.

[12]  P. Savage,et al.  Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins , 2004, Science.

[13]  H. Wakao,et al.  The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response , 2003 .

[14]  M. Sandrin,et al.  Characterization of the rat alpha(1,3)galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways. , 2003, Glycobiology.

[15]  Jang-June Park,et al.  Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-d-glucosylceramide synthase deficiency , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Grant,et al.  CD1-dependent dendritic cell instruction , 2002, Nature Immunology.

[17]  A. Rudensky,et al.  Thymocyte expression of cathepsin L is essential for NKT cell development , 2002, Nature Immunology.

[18]  M. Kronenberg,et al.  The unconventional lifestyle of NKT cells , 2002, Nature Reviews Immunology.

[19]  J. Yewdell,et al.  Recycling CD1d1 Molecules Present Endogenous Antigens Processed in an Endocytic Compartment to NKT Cells1 , 2002, The Journal of Immunology.

[20]  L. Teyton,et al.  A Thymic Precursor to the NK T Cell Lineage , 2002, Science.

[21]  A. Stewart,et al.  Techniques: Recombinogenic engineering--new options for cloning and manipulating DNA. , 2001, Trends in biochemical sciences.

[22]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[23]  R. Cummings,et al.  Expression Cloning of a New Member of the ABO Blood Group Glycosyltransferases, iGb3 Synthase, That Directs the Synthesis of Isoglobo-glycosphingolipids* , 2000, The Journal of Biological Chemistry.

[24]  H. Fujiwara,et al.  A Novel Function of Vα14+CD4+NKT Cells: Stimulation of IL-12 Production by Antigen-Presenting Cells in the Innate Immune System , 1999, The Journal of Immunology.

[25]  A. Ohta,et al.  The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells , 1999, The Journal of experimental medicine.

[26]  S. Munro,et al.  Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[28]  M. Kasahara,et al.  Chromosomal duplication and the emergence of the adaptive immune system. , 1997, Trends in genetics : TIG.

[29]  M. Kaplan,et al.  Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent Cells , 1997, Science.

[30]  Toshihiro Ito,et al.  Predominant expression of invariant Vα14+ TCR α chain in NK1.1+ T cell populations , 1995 .

[31]  O. Lantz,et al.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.

[32]  R. Good,et al.  An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[34]  D. Hansen,et al.  Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells. , 2004, International journal for parasitology.

[35]  P. Savage,et al.  Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail–truncated CD1d , 2002, Nature Immunology.

[36]  S. Porcelli,et al.  The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. , 1999, Annual review of immunology.

[37]  K. Rajewsky,et al.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.